JPS5088003A - - Google Patents

Info

Publication number
JPS5088003A
JPS5088003A JP49141098A JP14109874A JPS5088003A JP S5088003 A JPS5088003 A JP S5088003A JP 49141098 A JP49141098 A JP 49141098A JP 14109874 A JP14109874 A JP 14109874A JP S5088003 A JPS5088003 A JP S5088003A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP49141098A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5088003A publication Critical patent/JPS5088003A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
JP49141098A 1973-12-06 1974-12-06 Pending JPS5088003A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2360794A DE2360794C2 (de) 1973-12-06 1973-12-06 Verfahren zur Herstellung von Peptiden

Publications (1)

Publication Number Publication Date
JPS5088003A true JPS5088003A (ja) 1975-07-15

Family

ID=5900062

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49141098A Pending JPS5088003A (ja) 1973-12-06 1974-12-06

Country Status (12)

Country Link
US (1) US3960830A (ja)
JP (1) JPS5088003A (ja)
BE (1) BE823064A (ja)
CH (1) CH605679A5 (ja)
DE (1) DE2360794C2 (ja)
DK (1) DK633374A (ja)
FR (1) FR2253736B1 (ja)
GB (1) GB1464938A (ja)
IE (1) IE40281B1 (ja)
LU (1) LU71415A1 (ja)
NL (1) NL7415602A (ja)
SE (1) SE7415305L (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0520266U (ja) * 1991-01-31 1993-03-12 松下電器産業株式会社 電気部品の接続装置
WO2007034812A1 (ja) * 2005-09-20 2007-03-29 National University Corporation, Tokyo University Of Agriculture And Technology 分離用担体、化合物の分離方法、及びこれを用いたペプチド合成方法
JP2011140526A (ja) * 2007-11-21 2011-07-21 Solvay (Sa) ペプチド生成物

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997516A (en) * 1974-07-04 1976-12-14 Takeda Chemical Industries, Ltd. Method for protecting guanidino group and restoring the same
DE2930542A1 (de) * 1979-07-27 1981-02-12 Hoechst Ag Neue insulinderivate und verfahren zu ihrer herstellung
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US4908404A (en) * 1988-08-22 1990-03-13 Biopolymers, Inc. Synthetic amino acid-and/or peptide-containing graft copolymers
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5306500A (en) * 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
US5565519A (en) * 1988-11-21 1996-10-15 Collagen Corporation Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
EP0536671B1 (de) * 1991-10-07 1996-03-06 Hoechst Aktiengesellschaft Carbonsäureester-Schutzgruppen, ein Verfahren zu ihrer Herstellung, ihre Kopplung an eine funktionelle Gruppe sowie ihre Verwendung
US6458889B1 (en) 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US6833408B2 (en) * 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
US7883693B2 (en) * 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
DK2111876T3 (da) * 1995-12-18 2011-12-12 Angiodevice Internat Gmbh Tværbundne polymerpræparater og fremgangsmåder til anvendelse deraf
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
AU764144B2 (en) * 1998-08-28 2003-08-14 Gryphon Therapeutics, Inc. Polyamide chains of precise length, methods to manufacture them and their conjugates
ES2630278T3 (es) * 1998-10-16 2017-08-21 Biogen Ma Inc. Conjugados poliméricos de interferón beta-1a y usos de los mismos
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US8129330B2 (en) * 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
CA2511521C (en) 2002-12-30 2012-02-07 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2004060405A2 (en) * 2002-12-30 2004-07-22 Angiotech International Ag Tissue reactive compounds and compositions and uses thereof
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
WO2006083260A2 (en) 2004-04-28 2006-08-10 Angiotech Biomaterials Corporation Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
EP1789437A4 (en) * 2004-07-30 2008-11-05 Sinai School Medicine INHIBITORS OF NPC1L1 AND NPC1L1 AND METHODS OF USE THEREOF
WO2006034128A2 (en) 2004-09-17 2006-03-30 Angiotech Biomaterials Corporation Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
ES2456333T3 (es) * 2007-02-12 2014-04-22 Biotempt B.V. Tratamiento de hemorragia traumática con oligopéptidos cortos
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
NZ594302A (en) 2008-12-29 2013-07-26 Trevena Inc Beta-arrestin effectors and compositions and methods of use thereof
EP3102223A4 (en) * 2014-02-07 2017-11-29 Trevena, Inc. Crystalline and amorphous forms of a beta-arrestin effector
US9611293B2 (en) 2014-05-19 2017-04-04 Trevena, Inc. Synthesis of beta-arrestin effectors
EP3169406A4 (en) * 2014-07-14 2018-01-10 PEG Biosciences, Inc. Polymeric enkephalin prodrugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (ja) * 1967-05-23 1971-08-02 Pharmacia Ab
US3502545A (en) * 1968-09-27 1970-03-24 Monsanto Co Process for the separation of water-soluble polymeric materials from unbound protein or peptide using semiporous gel

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0520266U (ja) * 1991-01-31 1993-03-12 松下電器産業株式会社 電気部品の接続装置
WO2007034812A1 (ja) * 2005-09-20 2007-03-29 National University Corporation, Tokyo University Of Agriculture And Technology 分離用担体、化合物の分離方法、及びこれを用いたペプチド合成方法
JPWO2007034812A1 (ja) * 2005-09-20 2009-03-26 国立大学法人東京農工大学 分離用担体、化合物の分離方法、及びこれを用いたペプチド合成方法
JP2010116418A (ja) * 2005-09-20 2010-05-27 Jitsubo Co Ltd 分離用担体、化合物の分離方法、及びこれを用いたペプチド合成方法
JP4500854B2 (ja) * 2005-09-20 2010-07-14 Ｊｉｔｓｕｂｏ株式会社 分離用担体
US8633298B2 (en) 2005-09-20 2014-01-21 Jitsubo Co., Ltd. Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier
US9284348B2 (en) 2005-09-20 2016-03-15 Jitsubo Co., Ltd. Method for synthesis of peptide using a carrier
JP2011140526A (ja) * 2007-11-21 2011-07-21 Solvay (Sa) ペプチド生成物

Also Published As

Publication number Publication date
IE40281B1 (en) 1979-04-25
BE823064A (fr) 1975-06-06
IE40281L (en) 1975-06-06
NL7415602A (nl) 1975-06-10
DE2360794A1 (de) 1975-06-26
FR2253736A1 (ja) 1975-07-04
US3960830A (en) 1976-06-01
DE2360794C2 (de) 1984-12-06
SE7415305L (ja) 1975-06-09
FR2253736B1 (ja) 1978-09-15
GB1464938A (en) 1977-02-16
DK633374A (ja) 1975-07-21
CH605679A5 (ja) 1978-10-13
LU71415A1 (ja) 1976-11-11

Similar Documents

Publication Publication Date Title
AR201758A1 (ja)
AU476761B2 (ja)
AU465372B2 (ja)
FR2253736B1 (ja)
AR201235Q (ja)
AR201231Q (ja)
AU450229B2 (ja)
AU476714B2 (ja)
AR201229Q (ja)
AR199451A1 (ja)
AU492386B2 (ja)
AU477823B2 (ja)
AR196382A1 (ja)
AU476873B1 (ja)
AR200885A1 (ja)
AU471461B2 (ja)
AR200256A1 (ja)
AR210729A1 (ja)
AU447540B2 (ja)
AR201432A1 (ja)
AU477824B2 (ja)
AU461342B2 (ja)
AR197627A1 (ja)
AR196212Q (ja)
AR196123Q (ja)